Consensus interferon induces peak mRNA accumulation at lower concentrations than interferon-alpha 2a

Area of Science:

• Immunology and Molecular Biology
• Interferon research
• Recombinant protein therapeutics

Background:

• Interferon-alpha (IFN-alpha) subtypes exhibit diverse biological activities.
• A consensus sequence approach aims to create a more potent and effective interferon.
• Understanding interferon-inducible gene regulation is crucial for assessing therapeutic efficacy.

Purpose of the Study:

• To evaluate and compare the biological activity of a novel consensus recombinant interferon (r-metIFN-con1) against a standard IFN-alpha 2a.
• To quantify the effectiveness of both interferons by measuring the induction of IFN-inducible genes at the mRNA level.
• To determine the concentration-dependent efficacy and kinetic profiles of r-metIFN-con1 and IFN-alpha 2a.

Main Methods:

• Treatment of three distinct cell lines with equimolar concentrations of r-metIFN-con1 and IFN-alpha 2a across a 5-log range.
• Extraction of cellular mRNA at five time points post-treatment.
• Quantitative measurement of mRNA levels for three IFN-inducible genes, including HLA-DR alpha mRNA, to assess interferon-induced gene expression.

Main Results:

• r-metIFN-con1 consistently induced higher levels of IFN-inducible mRNAs at lower concentrations compared to IFN-alpha 2a.
• Both interferons showed similar mRNA accumulation kinetics at effective concentrations.
• r-metIFN-con1 demonstrated approximately 10-fold greater molar potency in gene induction.

Conclusions:

• r-metIFN-con1 exhibits enhanced efficacy in regulating IFN-inducible genes at the mRNA level compared to IFN-alpha 2a.
• The consensus interferon, r-metIFN-con1, represents a more potent therapeutic candidate, building upon previously reported antiviral and antiproliferative activities.
• These findings support the potential of consensus interferons for improved therapeutic outcomes.